{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/98221"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/98221","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Ultrasensitive quantification of circulating disease biomarkers through enzymatic labeling and single molecule counting","abstract":"The focus of my graduate research is on the development of simplified and ultrasensitive methods for quantifying low abundance biomarkers with the ultimate goal of developing robust tools for advancing disease diagnosis. In recent years there has been an immense expansion in the identification of sensitive and specific indicators of disease. As our understanding of these biochemical parameters continues to advance, the ability to quantify low abundance biomarkers from small samples sizes has become increasingly important to continue expanding the range of available disease indicators. Further, as medical diagnostics continues to transition to point-of-care testing, the development of simplified protocols capable of producing rapid results has been a main element limiting the development of portable devices. Together, each of these factors will play a critical role in the analysis of clinical samples for the purpose of providing more robust diagnostic and prognostic information to patients suffering from diseases ranging from infectious disease to cancer, metabolic, autoimmune, and gastrointestinal disorders. This thesis focuses on two independent projects which aim to address these limitations through the design of improved methods for the quantification of microRNA (miRNA) and protein in biological fluids. The first of my projects relates to the ultrasensitive detection of miRNA, one of the most exciting emerging classes of biomarkers. In recent years, miRNA in blood circulating have been identified as robust indicators of a variety of diseases. Despite extensive research into the potential impact of miRNAs as clinical indicators, state of the art methods remain dependent on incredibly complex and time consuming techniques. Together, these limitations have been main factors extending research timelines and precluding the development of POC assays. Main factors contributing to the complexity of existing tests include the dependence on reverse transcriptase, DNA ligase, and PCR steps, each of which necessitate time consuming reagent handling as well as 1-2 h incubations. To addresses these issues, my research has focused on the development of an efficient RNA amplification technique which uses enzymatic chemical labeling to generate densely labeled double stranded products that are then labeled with fluorescent probes. Individual molecules are then directly counted using total internal reflection fluorescence microscopy, as opposed to conventional indirect methods using the polymerase chain reaction (PCR). This technology provides a fundamental framework for the development of an ultrasensitive miRNA detection method which allows for the absolute and direct quantification of miRNAs in clinical samples. This thesis demonstrates enzymatic labeling of miRNA with fluorescent probes as well as the optimization of surface attachment and probe labeling methods. Ultimately this research concludes with the successful detection of labeled miRNA, establishing a framework for advancing the sensitivity of this method toward the fundamental level of digital single molecule counting.","abstract_html":"The focus of my graduate research is on the development of simplified and ultrasensitive methods for quantifying low abundance biomarkers with the ultimate goal of developing robust tools for advancing disease diagnosis. In recent years there has been an immense expansion in the identification of sensitive and specific indicators of disease. As our understanding of these biochemical parameters continues to advance, the ability to quantify low abundance biomarkers from small samples sizes has become increasingly important to continue expanding the range of available disease indicators. Further, as medical diagnostics continues to transition to point-of-care testing, the development of simplified protocols capable of producing rapid results has been a main element limiting the development of portable devices. Together, each of these factors will play a critical role in the analysis of clinical samples for the purpose of providing more robust diagnostic and prognostic information to patients suffering from diseases ranging from infectious disease to cancer, metabolic, autoimmune, and gastrointestinal disorders. This thesis focuses on two independent projects which aim to address these limitations through the design of improved methods for the quantification of microRNA (miRNA) and protein in biological fluids. The first of my projects relates to the ultrasensitive detection of miRNA, one of the most exciting emerging classes of biomarkers. In recent years, miRNA in blood circulating have been identified as robust indicators of a variety of diseases. Despite extensive research into the potential impact of miRNAs as clinical indicators, state of the art methods remain dependent on incredibly complex and time consuming techniques. Together, these limitations have been main factors extending research timelines and precluding the development of POC assays. Main factors contributing to the complexity of existing tests include the dependence on reverse transcriptase, DNA ligase, and PCR steps, each of which necessitate time consuming reagent handling as well as 1-2 h incubations. To addresses these issues, my research has focused on the development of an efficient RNA amplification technique which uses enzymatic chemical labeling to generate densely labeled double stranded products that are then labeled with fluorescent probes. Individual molecules are then directly counted using total internal reflection fluorescence microscopy, as opposed to conventional indirect methods using the polymerase chain reaction (PCR). This technology provides a fundamental framework for the development of an ultrasensitive miRNA detection method which allows for the absolute and direct quantification of miRNAs in clinical samples. This thesis demonstrates enzymatic labeling of miRNA with fluorescent probes as well as the optimization of surface attachment and probe labeling methods. Ultimately this research concludes with the successful detection of labeled miRNA, establishing a framework for advancing the sensitivity of this method toward the fundamental level of digital single molecule counting.","abstract_has_math":false,"creators":["Smith, Lucas David"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"M.S.","degree_level":"Thesis","degree_discipline":"Biology","degree_department":null,"school":null,"contributors":["Smith, Andrew M."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2017,"date_issued":"2017-09-29T16:39:04Z","date_published":"2017-09-29T16:39:04Z","updated_at":"2026-07-22T22:24:35Z","subjects":["Micro-ribonucleic acid (miRNA)","Deoxyribonucleic acid (DNA)","Synthesis","Microscopy","Single molecule imaging","Fluorophore","Circulating biomarker","Deoxyribonucleic acid (DNA) synthesis","Quantum dot"],"languages":["en"],"rights":["Copyright 2017 Lucas David Smith"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/2142/98221","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Smith, Andrew M."]},{"key":"dc:creator","label":"Author","values":["Smith, Lucas David"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2017-09-29T16:39:04Z","2019-09-30T09:15:32Z","2017-05-26","2017-08"]},{"key":"dc:type","label":"Dc Type","values":["text"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["M.S."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Micro-ribonucleic acid (miRNA)","Deoxyribonucleic acid (DNA)","Synthesis","Microscopy","Single molecule imaging","Fluorophore","Circulating biomarker","Deoxyribonucleic acid (DNA) synthesis","Quantum dot"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright 2017 Lucas David Smith"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/98221"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["The focus of my graduate research is on the development of simplified and ultrasensitive methods for quantifying low abundance biomarkers with the ultimate goal of developing robust tools for advancing disease diagnosis. In recent years there has been an immense expansion in the identification of sensitive and specific indicators of disease. As our understanding of these biochemical parameters continues to advance, the ability to quantify low abundance biomarkers from small samples sizes has become increasingly important to continue expanding the range of available disease indicators. Further, as medical diagnostics continues to transition to point-of-care testing, the development of simplified protocols capable of producing rapid results has been a main element limiting the development of portable devices. Together, each of these factors will play a critical role in the analysis of clinical samples for the purpose of providing more robust diagnostic and prognostic information to patients suffering from diseases ranging from infectious disease to cancer, metabolic, autoimmune, and gastrointestinal disorders. This thesis focuses on two independent projects which aim to address these limitations through the design of improved methods for the quantification of microRNA (miRNA) and protein in biological fluids. The first of my projects relates to the ultrasensitive detection of miRNA, one of the most exciting emerging classes of biomarkers. In recent years, miRNA in blood circulating have been identified as robust indicators of a variety of diseases. Despite extensive research into the potential impact of miRNAs as clinical indicators, state of the art methods remain dependent on incredibly complex and time consuming techniques. Together, these limitations have been main factors extending research timelines and precluding the development of POC assays. Main factors contributing to the complexity of existing tests include the dependence on reverse transcriptase, DNA ligase, and PCR steps, each of which necessitate time consuming reagent handling as well as 1-2 h incubations. To addresses these issues, my research has focused on the development of an efficient RNA amplification technique which uses enzymatic chemical labeling to generate densely labeled double stranded products that are then labeled with fluorescent probes. Individual molecules are then directly counted using total internal reflection fluorescence microscopy, as opposed to conventional indirect methods using the polymerase chain reaction (PCR). This technology provides a fundamental framework for the development of an ultrasensitive miRNA detection method which allows for the absolute and direct quantification of miRNAs in clinical samples. This thesis demonstrates enzymatic labeling of miRNA with fluorescent probes as well as the optimization of surface attachment and probe labeling methods. Ultimately this research concludes with the successful detection of labeled miRNA, establishing a framework for advancing the sensitivity of this method toward the fundamental level of digital single molecule counting.","Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2019-08-01","The student, Lucas Smith, accepted the attached license on 2017-05-25 at 11:06.","The student, Lucas Smith, submitted this Thesis for approval on 2017-05-25 at 11:35.","This Thesis was approved for publication on 2017-05-26 at 13:18.","DSpace SAF Submission Ingestion Package generated from Vireo submission #11179 on 2017-09-29 at 11:13:19","Made available in DSpace on 2017-09-29T16:39:04Z (GMT). No. of bitstreams: 2 SMITH-THESIS-2017.pdf: 3090249 bytes, checksum: c82b6b03b4efd25f822151dd8db6044d (MD5) LICENSE.txt: 4208 bytes, checksum: 4de45aa35db5751ccd23834b46a58797 (MD5) Previous issue date: 2017-05-26","Embargo set by: Colleen Fallaw for item 103368 Lift date: 2019-09-29T16:39:52Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Embargo set by: Colleen Fallaw for item 103368 Lift date: 2019-09-29T17:52:45Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Limited Restriction Lifted for Item 103368 on 2019-09-30T09:15:32Z."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Ultrasensitive quantification of circulating disease biomarkers through enzymatic labeling and single molecule counting"]}]}],"canonical_facts":{"dc:contributor":["Smith, Andrew M."],"dc:creator":["Smith, Lucas David"],"dc:date":["2017-09-29T16:39:04Z","2019-09-30T09:15:32Z","2017-05-26","2017-08"],"dc:description":["The focus of my graduate research is on the development of simplified and ultrasensitive methods for quantifying low abundance biomarkers with the ultimate goal of developing robust tools for advancing disease diagnosis. In recent years there has been an immense expansion in the identification of sensitive and specific indicators of disease. As our understanding of these biochemical parameters continues to advance, the ability to quantify low abundance biomarkers from small samples sizes has become increasingly important to continue expanding the range of available disease indicators. Further, as medical diagnostics continues to transition to point-of-care testing, the development of simplified protocols capable of producing rapid results has been a main element limiting the development of portable devices. Together, each of these factors will play a critical role in the analysis of clinical samples for the purpose of providing more robust diagnostic and prognostic information to patients suffering from diseases ranging from infectious disease to cancer, metabolic, autoimmune, and gastrointestinal disorders. This thesis focuses on two independent projects which aim to address these limitations through the design of improved methods for the quantification of microRNA (miRNA) and protein in biological fluids. The first of my projects relates to the ultrasensitive detection of miRNA, one of the most exciting emerging classes of biomarkers. In recent years, miRNA in blood circulating have been identified as robust indicators of a variety of diseases. Despite extensive research into the potential impact of miRNAs as clinical indicators, state of the art methods remain dependent on incredibly complex and time consuming techniques. Together, these limitations have been main factors extending research timelines and precluding the development of POC assays. Main factors contributing to the complexity of existing tests include the dependence on reverse transcriptase, DNA ligase, and PCR steps, each of which necessitate time consuming reagent handling as well as 1-2 h incubations. To addresses these issues, my research has focused on the development of an efficient RNA amplification technique which uses enzymatic chemical labeling to generate densely labeled double stranded products that are then labeled with fluorescent probes. Individual molecules are then directly counted using total internal reflection fluorescence microscopy, as opposed to conventional indirect methods using the polymerase chain reaction (PCR). This technology provides a fundamental framework for the development of an ultrasensitive miRNA detection method which allows for the absolute and direct quantification of miRNAs in clinical samples. This thesis demonstrates enzymatic labeling of miRNA with fluorescent probes as well as the optimization of surface attachment and probe labeling methods. Ultimately this research concludes with the successful detection of labeled miRNA, establishing a framework for advancing the sensitivity of this method toward the fundamental level of digital single molecule counting.","Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2019-08-01","The student, Lucas Smith, accepted the attached license on 2017-05-25 at 11:06.","The student, Lucas Smith, submitted this Thesis for approval on 2017-05-25 at 11:35.","This Thesis was approved for publication on 2017-05-26 at 13:18.","DSpace SAF Submission Ingestion Package generated from Vireo submission #11179 on 2017-09-29 at 11:13:19","Made available in DSpace on 2017-09-29T16:39:04Z (GMT). No. of bitstreams: 2 SMITH-THESIS-2017.pdf: 3090249 bytes, checksum: c82b6b03b4efd25f822151dd8db6044d (MD5) LICENSE.txt: 4208 bytes, checksum: 4de45aa35db5751ccd23834b46a58797 (MD5) Previous issue date: 2017-05-26","Embargo set by: Colleen Fallaw for item 103368 Lift date: 2019-09-29T16:39:52Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Embargo set by: Colleen Fallaw for item 103368 Lift date: 2019-09-29T17:52:45Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Limited Restriction Lifted for Item 103368 on 2019-09-30T09:15:32Z."],"dc:format":["application/pdf"],"dc:identifier":["http://hdl.handle.net/2142/98221"],"dc:language":["en"],"dc:rights":["Copyright 2017 Lucas David Smith"],"dc:subject":["Micro-ribonucleic acid (miRNA)","Deoxyribonucleic acid (DNA)","Synthesis","Microscopy","Single molecule imaging","Fluorophore","Circulating biomarker","Deoxyribonucleic acid (DNA) synthesis","Quantum dot"],"dc:title":["Ultrasensitive quantification of circulating disease biomarkers through enzymatic labeling and single molecule counting"],"dc:type":["text"],"thesis:degree_discipline":["Biology"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["M.S."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:24:35Z"}